Literature DB >> 9111068

Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4.

T Natsume1, S Tomita, S Iemura, N Kinto, A Yamaguchi, N Ueno.   

Abstract

Bone morphogenetic proteins (BMPs) are multifunctional proteins that comprise the largest subfamily of the transforming growth factor-beta. These proteins bind to types I and II serine/threonine kinase receptors. Ligand-induced heteromeric dimerization of these receptors is the key event in initiation of biological responses. We report here large-scale expression and purification of extracellular domain of the type I receptor for BMP-2/4, using a silkworm expression system. This soluble form of BMP receptor (sBMPR) was in monomer form in solution and bound to BMP-4 but not to activin or transforming growth factor-beta1. Surface plasmon resonance studies showed that kinetic parameters of sBMPR for BMP-4 consisted of a relatively rapid association rate constant (ka = 3.81 +/- 0.19 x 10(4) s-1 M-1) and an extremely slow dissociation rate constant (kd = 3.69 +/- 0.26 x 10(-4) s-1). From these two kinetic parameters, affinity was determined to be similar to that of the intact membrane-associated receptor expressed on COS cells. sBMPR inhibited the alkaline phosphatase activity in BMP responsive cell lines such as mouse osteoblastic cell MC3T3-E1 and bone marrow stromal cell ST2. These data indicate that the extracellular domain of type I receptor for BMP-2 and BMP-4 is sufficient for high-affinity binding to its ligands and should prove useful in understanding the role of BMP-2/4 in vivo, because a suitable high-affinity anti-BMP antibody has yet to be developed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111068     DOI: 10.1074/jbc.272.17.11535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Use of the SST-REX method for the identification of genes expressed at the condensation stage of chondrogenic cell line ATDC5.

Authors:  Atsushi Noguchi; Naoko Watanabe; Ryoji Fujimaki; Toshio Kitamura; Yoshihide Hayashizaki; Shigeru Miyaki; Kenichi Tezuka; Nobumichi Hozumi
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation.

Authors:  Nobuyuki Bokui; Takayuki Otani; Koichi Igarashi; Junichiro Kaku; Mitsuo Oda; Tadahiro Nagaoka; Masaharu Seno; Kenji Tatematsu; Toshihide Okajima; Takashi Matsuzaki; Kang Ting; Katsuyuki Tanizawa; Shun'ichi Kuroda
Journal:  FEBS Lett       Date:  2007-12-17       Impact factor: 4.124

3.  Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways.

Authors:  Y Ying; X Qi; G Q Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

4.  Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres.

Authors:  E Bergeron; M E Marquis; I Chrétien; N Faucheux
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

5.  A functional bone morphogenetic protein system in the ovary.

Authors:  S Shimasaki; R J Zachow; D Li; H Kim; S Iemura; N Ueno; K Sampath; R J Chang; G F Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.

Authors:  Kai Heinecke; Axel Seher; Werner Schmitz; Thomas D Mueller; Walter Sebald; Joachim Nickel
Journal:  BMC Biol       Date:  2009-09-07       Impact factor: 7.431

7.  Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization.

Authors:  Wan-Jong Kuo; Michelle A Digman; Arthur D Lander
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

8.  Bone morphogenetic protein signaling: implications in urology.

Authors:  Jeongyun Jeong; Dong Il Kang; Geun Taek Lee; Isaac Yi Kim
Journal:  Korean J Urol       Date:  2010-08-18

9.  Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo.

Authors:  S Iemura; T S Yamamoto; C Takagi; H Uchiyama; T Natsume; S Shimasaki; H Sugino; N Ueno
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood.

Authors:  M Cristina Nostro; Xin Cheng; Gordon M Keller; Paul Gadue
Journal:  Cell Stem Cell       Date:  2008-01-10       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.